日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transferrin receptor 1 nuclear translocation facilitates tumor progression via p53-mediated chromatin interactions and genome-wide alterations

转铁蛋白受体1核转位通过p53介导的染色质相互作用和全基因组改变促进肿瘤进展

Yaxin Hou # ,Guoheng Tang # ,Qizhi Wang ,Meng Zhou ,Ran Xu ,Xuehui Chen ,Guizhi Shi ,Zhuoran Wang ,Xiyun Yan ,Jie Zhuang ,Kelong Fan

Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer

突变型p53利用增强子提高免疫抑制性趋化因子的表达,并削弱胰腺癌中的免疫检查点抑制剂的作用。

Dig B Mahat ,Heena Kumra ,Sarah A Castro ,Emily Metcalf ,Kim Nguyen ,Ryo Morisue ,William W Ho ,Ivy Chen ,Brandon Sullivan ,Leon H Yim ,Arundeep Singh ,Jiayu Fu ,Sean K Waterton ,Yu-Chi Cheng ,Enrico Moiso ,Vikash P Chauhan ,Hernandez Moura Silva ,Stefani Spranger ,Rakesh K Jain ,Phillip A Sharp

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

恢复TP53-Y220C突变型急性髓系白血病中p53野生型构象

Bing Z Carter ,Po Yee Mak ,Edward Ayoub ,Xiaogang Wu ,Baozhen Ke ,Yuki Nishida ,Andrew Futreal ,Lauren B Ostermann ,Andrea D Bedoy ,Steffen Boettcher ,Courtney D DiNardo ,Anna Puzio-Kuter ,Masha V Poyurovsky ,Arnold Levine ,Michael Andreeff

Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response

移植后G-CSF通过加剧p53介导的DNA损伤反应,阻碍基因编辑的人造血干细胞的植入。

Daisuke Araki ,Vicky Chen ,Neelam Redekar ,Christi Salisbury-Ruf ,Yan Luo ,Poching Liu ,Yuesheng Li ,Richard H Smith ,Pradeep Dagur ,Christian Combs ,Andre Larochelle

Suppression of stress granule formation is a vulnerability imposed by mutant p53

突变型p53导致应激颗粒形成受到抑制,这是一种脆弱性。

Elizabeth Thoenen ,Atul Ranjan ,Alejandro Parrales ,Shigeto Nishikawa ,Dan A Dixon ,Sugako Oka ,Tomoo Iwakuma

PPIL2 is a target of the JAK2/STAT5 pathway and promotes myeloproliferation via degradation of p53

PPIL2是JAK2/STAT5通路的一个靶点,它通过降解p53促进骨髓增殖。

Pan Wang ,Xu Han ,Kehan Ren ,Ermin Li ,Honghao Bi ,Inci Aydemir ,Madina Sukhanova ,Yijie Liu ,Jing Yang ,Peng Ji

The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect

p53错义变异体R248Q的半衰期延长,促进其积累并与野生型p53形成异源四聚体,从而发挥显性负效应。

Nancy Klemm,Roman R Schimmer,Nils K Konrad,Flavian Thelen,Jonas Fullin,Ebru Topçu,Christian Koch,Milena Treacy,Matthew Joseph Leventhal,Marco M Bühler,Veronika Lysenko,Alexandre P A Theocharides,Kari J Kurppa,Stefan Balabanov,Tuncay Baubec,Andrei V Krivtsov,Peter G Miller,Scott A Armstrong,Benjamin L Ebert,Markus G Manz,Cesar Nombela-Arrieta,Steffen Boettcher

Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses

药物挽救突变型p53可通过免疫反应触发肿瘤自发性消退

Jiabing Li ,Shuang Zhang ,Baohui Wang ,Yuting Dai ,Jiale Wu ,Dianjia Liu ,Ying Liang ,Shujun Xiao ,Zhengyuan Wang ,Jiaqi Wu ,Derun Zheng ,Xueqin Chen ,Fangfang Shi ,Kai Tan ,Xianting Ding ,Huaxin Song ,Sujiang Zhang ,Min Lu

Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway

克拉屈滨通过非经典P53/STING通路诱导肿瘤细胞凋亡、GSDME相关细胞焦亡以及CD8+ T细胞抗肿瘤活性。

Jie Wu # ,Nian Liu # ,Jing Chen ,Qian Tao ,Can Lu ,Qiuqiu Li ,Xiang Chen ,Cong Peng

The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations

抑制因子Capicua是Kras/Trp53突变驱动的肺肿瘤发展的屏障。

Irene Ballesteros-González ,Iván Hernández-Navas ,Oksana Brehey ,Carmen G Lechuga ,Marina Salmón ,Morena Scotece ,Ricardo Velasco-Vicente ,Alejandra A Flores-Gómez ,Antonio Cebriá ,Lucía Simón-Carrasco ,Gerardo Jiménez ,Monica Musteanu ,Carmen Guerra ,Orlando Domínguez ,Eduardo Caleiras ,Carmen Blanco-Aparicio ,Tirso Pons ,Irene Ferrer ,Luis Paz-Ares ,Raul Torres-Ruiz ,Sandra Rodríguez-Perales ,Mariano Barbacid ,Matthias Drosten